United Therapeutics Corporation 13D and 13G filings for Celularity Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-08 06:00 am Unchanged | 2023-12-31 | 13G | Celularity Inc. CELU | UNITED THERAPEUTICS Corp UTHR | 796,885 4.110% | 0 (Unchanged) | Filing |
| 2023-02-06 06:01 am Unchanged | 2022-12-31 | 13G | Celularity Inc. CELU | UNITED THERAPEUTICS Corp UTHR | 796,885 5.500% | 0 (Unchanged) | Filing |
| 2023-02-03 07:28 am Purchase | 2021-07-16 | 13G | Celularity Inc. CELU | UNITED THERAPEUTICS Corp UTHR | 796,885 6.510% | 796,885 (New Position) | Filing |
| 2023-02-03 06:02 am Sale | 2021-07-16 | 13G | Celularity Inc. CELU | UNITED THERAPEUTICS Corp UTHR | 0 0.000% | -796,885 (Position Closed) | Filing |
| 2022-02-04 4:31 pm Purchase | 2021-07-16 | 13G | Celularity Inc. CELU | UNITED THERAPEUTICS Corp UTHR | 796,885 6.510% | 796,885 (New Position) | Filing |